Author:
Akinduti Paul Akinniyi,Motayo Babatunde Olanrewaju,Maged El-Ashker,Isibor Patrick Omoregie
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Reddy, P. N., Srirama, K. & Dirisala, V. R. An update on clinical burden, diagnostic tools, and therapeutic options of Staphylococcus aureus. Infect. Dis. Res. Treat. 10, 1179916117703999 (2017).
2. Sanders, T., Bentum, J., Fox, A., Egyir, B. & Watters, C. Characterization of MRSA and ESBL pathogens from patients with surgical-site infections in Accra Ghana. Antimicrob. Steward. Healthc. Epidemiol. 2(S1), s86–s86 (2022).
3. Ghaznavi-Rad, E. et al. Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J. Clin. Microbiol. 48(3), 867–872 (2010).
4. Abd El-Hamid, M. I. et al. Clonal diversity and epidemiological characteristics of ST239-MRSA strains. Front. Cell. Infect. Microbiol. 25(12), 782045 (2022).
5. Sartelli, M. et al. WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections. World J. Emerg. Surg. 17(1), 1–23 (2022).